DK457286D0 - Fluorenforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse - Google Patents

Fluorenforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse

Info

Publication number
DK457286D0
DK457286D0 DK457286A DK457286A DK457286D0 DK 457286 D0 DK457286 D0 DK 457286D0 DK 457286 A DK457286 A DK 457286A DK 457286 A DK457286 A DK 457286A DK 457286 D0 DK457286 D0 DK 457286D0
Authority
DK
Denmark
Prior art keywords
sup
carbon atoms
connection
pharmaceutical preparation
preparation containing
Prior art date
Application number
DK457286A
Other languages
English (en)
Other versions
DK457286A (da
Inventor
Jr Edward J Cragoe
Jr Otto W Woltersdorf
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK457286D0 publication Critical patent/DK457286D0/da
Publication of DK457286A publication Critical patent/DK457286A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
DK457286A 1985-09-26 1986-09-25 Fluorenforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse DK457286A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/780,145 US4604396A (en) 1985-09-26 1985-09-26 [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)oxy]ethanimidamides and [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)oxy]ethanimidic acid hydrazides, their derivatives and their salts

Publications (2)

Publication Number Publication Date
DK457286D0 true DK457286D0 (da) 1986-09-25
DK457286A DK457286A (da) 1987-03-27

Family

ID=25118757

Family Applications (1)

Application Number Title Priority Date Filing Date
DK457286A DK457286A (da) 1985-09-26 1986-09-25 Fluorenforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse

Country Status (8)

Country Link
US (1) US4604396A (da)
EP (1) EP0217287B1 (da)
JP (1) JPS6284052A (da)
AT (1) ATE64733T1 (da)
CA (1) CA1284329C (da)
DE (1) DE3679955D1 (da)
DK (1) DK457286A (da)
ES (1) ES2001801A6 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769370A (en) * 1986-09-24 1988-09-06 Merck & Co., Inc. (1,2-dichloro-8-oxo-5a-substituted-5a,6,7,8-tetrahydrodibenzofuran-3-yl)alkanoic acids and alkanimidamides
US4797391A (en) * 1986-09-24 1989-01-10 Merck & Co., Inc. ((5,6-dichloro-3-oxo-9,9a-disubstituted-2,3,9,9a-tetrahydrofluoren-7-yl)oxy)alkanoic acids and alkanimidamides
US4731471A (en) * 1986-11-03 1988-03-15 Merck & Co., Inc. (5,6-dichloro-3-oxo-2,3,9,9a-tetrahydrofluoren-7-yl)-alkanoic acids and alkanimidamides bearing novel functional 9a-substituents
US4782073A (en) * 1986-12-24 1988-11-01 Merck & Co., Inc. Amides of [(5,6-dichloro-3-oxo-9-alpha-substituted-2,3,9,9-alpha-tetrahydrofluoren-7-yl-oxyl]acetic acids, and pharmaceutical compositions thereof
US4771076A (en) * 1987-06-01 1988-09-13 Merck & Co., Inc. [(2-substituted 1,2-dihydro-1-oxo-1H-inden-5-yl)oxy]alkanesulfonic acids and salts thereof
US4775695A (en) * 1987-06-01 1988-10-04 Merck & Co., Inc. Substituted amidinoalkoxy and amidinoalkylamino indanones and salts thereof
JP4674339B2 (ja) * 1998-08-07 2011-04-20 三菱化学株式会社 脳損傷の予防・治療剤
US6251898B1 (en) * 1999-08-24 2001-06-26 Questcor Pharmaceuticals, Inc. Medical use of fluorenone derivatives for treating and preventing brain and spinal injury
WO2001082923A1 (en) * 2000-02-14 2001-11-08 Merck & Co., Inc. Estrogen receptor modulators
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6903105B2 (en) 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
AR051597A1 (es) * 2004-11-01 2007-01-24 Merck & Co Inc Moduladores de los receptores de estrogeno
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
CN105073717B (zh) 2012-12-17 2018-05-22 帕里昂科学公司 可用于治疗由黏膜水化不足造成的疾病的氯-吡嗪甲酰胺衍生物
CN108658876A (zh) 2012-12-17 2018-10-16 帕里昂科学公司 3,5-二氨基-6-氯-n-(n-(4-苯基丁基)甲脒基)吡嗪-2-甲酰胺化合物
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
CN110054580A (zh) * 2019-05-22 2019-07-26 苏州百灵威超精细材料有限公司 4-(4-n-马来酰亚胺苯基)丁酸酰肼盐酸盐的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337354A (en) * 1979-10-19 1982-06-29 Merck & Co., Inc. [(5,6,9a-Substituted-3-oxo-1,2,9,9a-tetrahydro-3H-fluoren-7-yl)oxy]alkanoic and cycloalkanoic acids, their analogs, esters, salts, and derivatives
US4317922A (en) * 1979-10-19 1982-03-02 Merck & Co., Inc. [(5,6,9a-Substituted-3-oxo-1,2,9,9a-tetrahydro-3H-fluoren-7-yl)oxy]alkanoic and cycloalkanoic acids and their analogs, esters, salts and derivatives
US4356313A (en) * 1979-10-19 1982-10-26 Merck & Co., Inc. [(5,6,9a-substituted-3-oxo-1,2,9,9a-tetrahydro-3H-fluoren-7-yl)oxy]alkanoic and cycloalkanoic acid esters and their analogs, the parent acids and their salts
GR70295B (da) * 1979-10-19 1982-09-06 Merck & Co Inc
US4356314A (en) * 1980-06-30 1982-10-26 Merck & Co., Inc. [5,6,9A-Substituted-3-oxo-1,2,9,9a-tetrahydro-3H-fluoren-7-yl)oxy]alkanoic and cycloalkanoic acids, their analogs, esters, salts, and derivatives
US4316043A (en) * 1980-12-19 1982-02-16 Merck & Co., Inc. [(5,6,9a-Substituted-3-oxo-1,2,9,9a-tetrahydro-3H-fluoren-7-yl)oxy]alkanoic and cycloalkanoic acids and their analogs, esters, salts and derivatives

Also Published As

Publication number Publication date
EP0217287A3 (en) 1988-07-20
CA1284329C (en) 1991-05-21
JPS6284052A (ja) 1987-04-17
ES2001801A6 (es) 1988-06-16
EP0217287B1 (en) 1991-06-26
DK457286A (da) 1987-03-27
EP0217287A2 (en) 1987-04-08
ATE64733T1 (de) 1991-07-15
US4604396A (en) 1986-08-05
DE3679955D1 (de) 1991-08-01

Similar Documents

Publication Publication Date Title
DK457286A (da) Fluorenforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
MX9306831A (es) Nuevos compuestos heterociclicos.
NO882608D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyrideirer.
NO903438L (no) Fremgangsmaate for fremstilling av tiazolderivater.
NO163956C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive (4-piperidinylmetyl- og -hetero)puriner.
ES2173074T3 (es) Derivados de xantina, procedimiento para su preparacion y su uso farmaceutico.
DK0467248T3 (da) Pyrazolopyridinforbindelse og fremgangsmåder til fremstilling heraf
PT82854A (en) Process for the preparation of pyridonocarboxylic acid derivatives
FI894693A0 (fi) Menetelmä valmistaa farmaseuttisesti arvokasta imidatsoliinijohdannaista
GB8401093D0 (en) Cephem compounds
IL85725A0 (en) Imidazole derivatives,their manufacture and pharmaceutical compositions containing them
IL89942A (en) Heterotetracyclic lactam derivatives, their preparation and pharmaceutical compositions containing them
ES8404981A1 (es) Un procedimiento para preparar guanidino-fenilamidinas heterociclicas sustituidas.
ZA899321B (en) Indole derivatives,process for preparing them and pharmaceutical compositions containing them
HU913293D0 (en) Process for the production of pierazine derivatives and medical preparations containing them
ATE18993T1 (de) Dibenzocycloheptenyliden-verbindungen zur verwendung bei der modulation der immunreaktion.
ES8405020A1 (es) Un procedimiento para la preparacion de derivados de fosfolipidos.
DK356287D0 (da) 2,6-piperazindionderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
FI831051L (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-pyrrolin-2-karbonitril-derivat
DE3271277D1 (en) Tropyl and pseudotropyl alkyl-benzoates and their use in migraine treatment
ZA905924B (en) N-(23-vincristinoyl)and n-(5'-noranhydro-23-vinblastinyol)derivatives of 1-aminomethylphosphonic acid,process for preparing these and pharmaceutical compositions containing them
ZA872925B (en) Heterocyclic compounds

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment